FDA Approval Status and Availability This section outlines the most practical distinction between the two agents for patients evaluating their immediate options
Key points from the advisory: No direct-to-consumer advertising of these medicines No surrogate or indirect promotion through influencers, obesity campaigns, or brand recall activities Avoid misleading weight-loss claims in promotional communication Sale strictly on prescription by a registered medical practitioner This reminder reinforces the provisions under the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 and the Drugs and Cosmetics Act, 1940, which prohibit public advertising of prescription medicines in India
The triple-receptor mechanism may offer some advantages for weight maintenance at lower doses, as the glucagon receptor activitys effect on metabolic rate could provide additional buffer against regain, but this remains theoretical until dedicated maintenance studies are published
During meals, the gallbladder releases bile into the small intestine to assist in digestion
If you notice consistent weight regain, consult your healthcare provider to discuss whether resuming medication or exploring alternative treatments is appropriate